News

  • Jaxon Russell features in Hudson Institute's 2019 Annual Report, Targeting childhood cancer

    Targeting childhood cancer | Jaxon’s story

    Sarah Russell knew something was gravely wrong with one of her twins, five-year-old Jaxon, when he became seriously ill with vomiting, nausea and unusual bruising, while his brother, Hunter, remained well.…  Read more

  • Dr Shanti Gurung from the Endometrial Stem Cell Biology Research Group at Hudson Institute

    Boosting embryo implantation success

    During infertility treatment, the failure of an embryo to implant in the uterus lining is still a major hurdle to a successful pregnancy for many women.…  Read more

  • Dr Jun Yang from the Cardiovascular Endocrinology Research Group at Hudson Institute

    High blood pressure service increases referrals

    A clinical service and primary care outreach program focused on hormonal causes of high blood pressure — the first of its kind in Victoria — has led to earlier screening and diagnosis of primary aldosteronism.…  Read more

  • Ruby Oberin and Penny Whiley, Centre Reproductive Health 3MT winners

    Reproductive health three minute thesis winners announced

    Following a very successful CRH 3MT competition held via zoom last Wednesday, 20 May 2020, the prestigious judging panel, including Prof Jock Findlay, A/Prof Peter Stanton, Dr Tracey Edgell, Dr Rukmali Wijayarathna and Ann Scott, announced this year’s winners were…  Read more

  • Dr Shayanti Mukherjee from the Endometrial Stem Cell Biology Research Group at Hudson Institute

    Pelvic organ prolapse treatment closer

    A revolutionary technology to treat pelvic organ prolapse is one step closer after the latest results from a Hudson Institute study.…  Read more

  • Edward Giles from the Regulation of Interferon and Innate Signalling Research Group at Hudson Institute

    Crohn’s disease diagnosis impacts future health

    Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.…  Read more

  • Dr Beth Allison from the Neurodevelopment and Neuroprotection Research Group at Hudson Institute

    Fetal growth restriction treatment findings

    Treatments given postnatally to babies who have experienced fetal growth restriction (FGR) during pregnancy need to be carefully considered, following new light shed on the topic by cell therapy research.…  Read more

  • Dr Rosemary Horne and Dr Jun Yang, National Health and Medical Research Council Investigator Grants

    NHMRC Investigator Grants success

    Hudson Institute is delighted to announce the success of our researchers in the latest NHMRC Investigator Grant round. Internationally-renowned childhood sleep expert Professor Rosemary Horne has been awarded more than $2 million to pursue studies investigating the implications of impaired sleep on the developing brain, while Dr Jun Yang has been awarded more than half…  Read more

  • Professor Peter Fuller AM and Dr Simon at the Hudson Institute of Medical Research

    $2.2 million awarded to tackle rare ovarian cancer

    Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods.…  Read more

  • Dr Robin Hobbs in the lab with PhD student Mai La.

    Male infertility expert joins Hudson Institute

    Dr Robin Hobbs has joined Hudson Institute as Group Head, Germline Stem Cell Biology. We welcome him and his team, including postdoctoral scientists Dr Ai-Leen Chan and Dr Julien Legrand, and PhD student Mai La.…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected